Abstract
Septic arthritis is a rheumatologic emergency as joint destruction occurs rapidly and can lead to significant morbidity and mortality. Accurate diagnosis can be particularly challenging in patients with underlying inflammatory joint disease. This review outlines the risk factors for septic arthritis and summarizes the causative bacterial organisms. We highlight advances in antibiotic management with a focus on new drugs for methicillin-resistant Staphylococcus aureus (MRSA) and discuss the use of adjunctive therapies for treatment of septic arthritis in adults.
Original language | English (US) |
---|---|
Article number | 332 |
Journal | Current rheumatology reports |
Volume | 15 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2013 |
Keywords
- Antibiotic management
- Bisphosphonates
- Ceftaroline
- Clinical management
- Daptomycin
- Diagnosis
- Joint drainage
- Linezolid
- MRSA
- Prosthetic joint infections
- Quinupristin-dalfopristin
- Risk factors
- Septic arthritis
- Steroids
- Treatment
ASJC Scopus subject areas
- Rheumatology